Articles by Sarah Chen
XRP Stalls Near $1.43 as Traders Eye Key $1.46 Resistance Level
XRP is trading near $1.43, having retreated from a Friday high above $1.50. Traders are monitoring $1.41 support and a $1.46-$1.50 resistance zone, with recent ETF inflows providing a bullish catalyst.
Alphabet Shares Dip Amid AI Chip Talks, Investor Focus on Spending
Alphabet shares declined 0.9% Monday as reports emerged of Google negotiating with Marvell Technology on AI chip development, despite ongoing investor unease about the company's substantial capital expenditure plans. Marvell stock surged 6.1% on the news.
Walmart Pilots Backroom Fulfillment to Accelerate Marketplace Delivery
Walmart is piloting a program in Dallas that uses store backrooms to hold third-party marketplace inventory for faster same-day delivery, a strategic move to compete with Amazon's delivery speed.
Oracle Shares Flat as AWS Partnership Fails to Ignite AI Revenue Optimism
Oracle shares were nearly unchanged Monday as the market assessed whether its new AWS Interconnect integration will generate sustainable AI income. The stock remains significantly below its peak from last September.
AMD Shares Dip After Rally as Analysts Boost Targets on AI CPU Demand
AMD shares declined 1.4% on Monday, cooling off after a record-breaking rally, while analysts at Bank of America and Stifel increased their price targets, highlighting growing AI infrastructure demand for central processors.
Hims & Hers Soars on FDA Catalyst as Omnicell Underperforms
Hims & Hers Health shares surged nearly 9% Monday, extending a strong weekly gain ahead of its May earnings report and a key FDA meeting on peptides. Omnicell reported mixed Q4 results with a net loss.
Broadcom's AI Surge Faces Test as Google Explores Marvell Chip Deal
Broadcom shares declined after reports surfaced that Google is in discussions with Marvell Technology for new AI chips, potentially impacting Broadcom's custom silicon business. Despite this, Broadcom's AI revenue soared 106% last quarter to $8.4 billion.
Lilly Acquires Kelonia in $7B Bet on In-Body CAR-T Cancer Therapy
Eli Lilly will purchase Kelonia Therapeutics in a deal valued at up to $7 billion, gaining an experimental in-body CAR-T therapy for blood cancer. Lilly shares rose 2.5% on the news.
XRP Holds Steady Near $1.40 Amid Geopolitical Tensions, Solana Integration
XRP traded sideways near $1.40 early Monday, showing resilience as broader markets turned cautious. The token's market capitalization remained around $87 billion with $3 billion in daily volume.
Hoskinson: XRP Holders Lack Claim to Ripple's Corporate Gains as Cardano Advances DeFi Integration
Charles Hoskinson clarifies that XRP ownership does not grant rights to Ripple's corporate profits, even as Cardano continues developing its plan to incorporate XRP into its decentralized finance infrastructure.
Google in Talks with Marvell for Custom AI Chips, Boosting Custom Silicon Race
Alphabet's Google is in discussions with Marvell Technology to design two new AI chips, according to a report. The move would deepen Marvell's role in the custom chip market for cloud giants.